Oral GLP-1s getting closer

Healthed

writer

Healthed

Healthed

Lilly releases topline trial results for its daily pill; Novo Nordisk awaits FDA decision on its own oral formulation…

Lilly released topline trial results for its oral GLP-1, orforglipron, on Thursday night, announcing an average weight loss of 12.4% and 12.4 kg among participants taking the highest dose (36mg).

The phase 3 ATTAIN-1 trial compared the daily pill against placebo at 72 weeks.

“In a key secondary endpoint, 59.6% of participants taking the highest dose of orforglipron lost at least 10% of their body weight, while 39.6% lost at least 15% of their body weight,” according to Lilly’s press release.

Patients taking the 12mg dose lost an average of 9.3% of their body weight, while those taking the 6mg dose lost an average of 7.8%.

By contrast, in the SURMOUNT-1 trial, Lilly’s injectable weight loss drug tirzepatide achieved average weight loss of approximately 15% at the 5mg dose, 19.5% at the 10 mg dose and 20.9% at the 15mg dose.

In May, Novo Nordisk filed an application to the FDA for its oral formulation of semaglutide in a 25mg dose, with participants reportedly achieving an average reduction of 13.6% of their body weight. A decision from the FDA is expected in Q4 this year.

Lilly says the detailed ATTAIN-1 results will be presented in September at the European Association for the Study of Diabetes Annual Meeting 2025 and published in a peer-reviewed journal.

Watch this space.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Acutely Painful Shoulder – Assessment and Management in GP

Dr Richard Phoon

Dr Richard Phoon

Chronic Kidney Disease – Delay Progression and Prevent Dialysis

Prof Rodney Baber AM

Prof Rodney Baber AM

Understand & Explain the Risks & Side Effects of MHT

Prof Peter Richmond

Prof Peter Richmond

Invasive Pneumococcal Disease – What GPs Need to Know

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Healthed

writer

Healthed

Test your knowledge

Recent articles

Latest GP poll

In your perception, how has Donald Trump's election to the US and related political discourse in the media concerning vaccine safety impact on your patients' willingness to follow Australian government recommended vaccinations?

Very negative impact

0%

Somewhat negative impact

0%

No noticeable impact

0%

Somewhat positive impact

0%

Very positive impact

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Tuesday 14th October, 7pm - 9pm AEDT

Speaker

Dr Sushil Pant

Orthopaedic Surgeon; Sydney Sports Medicine Centre

We invite you to our next free webcast, where Dr Sushil Pant will present on acutely painful shoulder. Up to 4 hours CPD. RACGP & ACRRM accredited.